INNOCARE(09969) - 2025 Q4 - Earnings Call Transcript

InnoCare Pharma (SEHK:09969) Q4 2025 Earnings call March 25, 2026 08:30 AM ET Company ParticipantsCarrie Zhou - VP of Medical ResearchChen Chen - Executive Director and Head of China HealthcareJasmine Cui - Co-Founder, Chairwoman, and CEOJason Zhang - Head of Pharmacology and Translational MedicineRenbin Zhao - SVP of Medical Research and Clinical DevelopmentXiangyang Chen - CTOXin Fu - CFOConference Call ParticipantsZiyi Chen - China Healthcare AnalystNone - AnalystZiyi ChenGreat. Good morning and good eve ...